Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Thermo Fisher Scientific Inc (NYSE: TMO) was $611.2 for the day, up 3.15% from the previous closing price of $592.51. In other words, the price has increased by $3.15 from its previous closing price. On the day, 2.49 million shares were traded. TMO stock price reached its highest trading level at $611.38 during the session, while it also had its lowest trading level at $592.56.
Ratios:
Our analysis of TMO’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 64.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.58. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.62.
On December 09, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $685.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on December 08, 2025, while the target price for the stock was maintained at $750.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 04 ’25 when Lagarde Michel sold 22,046 shares for $563.56 per share. The transaction valued at 12,424,244 led to the insider holds 84,117 shares of the business.
Lagarde Michel sold 32,000 shares of TMO for $18,668,526 on Dec 03 ’25. The Executive Vice President & COO now owns 65,480 shares after completing the transaction at $583.39 per share. On Dec 02 ’25, another insider, Lagarde Michel, who serves as the Executive Vice President & COO of the company, sold 30,000 shares for $581.92 each. As a result, the insider received 17,457,600 and left with 29,480 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMO now has a Market Capitalization of 229632770048 and an Enterprise Value of 261902761984. As of this moment, Thermo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.31, and their Forward P/E ratio for the next fiscal year is 24.83. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.25 while its Price-to-Book (P/B) ratio in mrq is 4.50. Its current Enterprise Value per Revenue stands at 5.988 whereas that against EBITDA is 24.172.
Stock Price History:
The Beta on a monthly basis for TMO is 0.93, which has changed by 0.08587921 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, TMO has reached a high of $610.97, while it has fallen to a 52-week low of $385.46. The 50-Day Moving Average of the stock is 6.13%, while the 200-Day Moving Average is calculated to be 25.76%.
Shares Statistics:
TMO traded an average of 1.72M shares per day over the past three months and 1335680 shares per day over the past ten days. A total of 375.71M shares are outstanding, with a floating share count of 374.83M. Insiders hold about 0.23% of the company’s shares, while institutions hold 91.77% stake in the company. Shares short for TMO as of 1765756800 were 5086563 with a Short Ratio of 2.96, compared to 1763078400 on 5462612. Therefore, it implies a Short% of Shares Outstanding of 5086563 and a Short% of Float of 1.3599999999999999.
Dividends & Splits
With its trailing 12-month dividend rate of 1.68, TMO has a forward annual dividend rate of 1.72. Against a Trailing Annual Dividend Yield of 0.002835395. The stock’s 5-year Average Dividend Yield is 0.24. The current Payout Ratio is 9.43% for TMO, which recently paid a dividend on 2025-12-15 with an ex-dividend date of 2025-12-15. Stock splits for the company last occurred on 1996-06-06 when the company split stock in a 3:2 ratio.
Earnings Estimates
Currently, 21.0 analysts are dedicated to thoroughly evaluating and rating the performance of Thermo Fisher Scientific Inc (TMO) in the stock market.The consensus estimate for the next quarter is $5.58, with high estimates of $5.84 and low estimates of $5.38.
Analysts are recommending an EPS of between $22.81 and $22.51 for the fiscal current year, implying an average EPS of $22.73. EPS for the following year is $24.66, with 27.0 analysts recommending between $25.87 and $24.0.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 19 analysts. It ranges from a high estimate of $12.01B to a low estimate of $11.82B. As of. The current estimate, Thermo Fisher Scientific Inc’s year-ago sales were $11.39BFor the next quarter, 19 analysts are estimating revenue of $11.03B. There is a high estimate of $11.25B for the next quarter, whereas the lowest estimate is $10.87B.
A total of 25 analysts have provided revenue estimates for TMO’s current fiscal year. The highest revenue estimate was $44.44B, while the lowest revenue estimate was $43.71B, resulting in an average revenue estimate of $44.28B. In the same quarter a year ago, actual revenue was $42.88BBased on 24 analysts’ estimates, the company’s revenue will be $46.54B in the next fiscal year. The high estimate is $46.93B and the low estimate is $46.01B.
